Atovaquone

Product NDC: 70166-488
Requested package NDC: 70166-488-05
11-digit product format: 701660488
Labeler code: 70166
Product ID: 70166-488_30ca1c6b-6bc5-3dba-e063-6394a90a5656
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Atovaquone
Dosage form: SUSPENSION
Route: ORAL
Labeler: Lohxa
Application: ANDA210692
Marketing category: ANDA
Marketing start: 2018-10-11
Substance: ATOVAQUONE
Active strength: 750 mg/5mL
Pharmacologic classes: Antimalarial [EPC], Antiprotozoal [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	70166-488	70166-488-05	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source date	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A210692-001	ATOVAQUONE	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB		2018-10-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A210692-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A210692-001	ATOVAQUONE	750MG/5ML	SUSPENSION / ORAL	AB	2018-10-11	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A210692-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210692-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210692-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210692-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210692-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210692-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210692-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210692-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210692-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210692-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210692-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210692-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210692-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210692-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210692-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210692-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210692-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210692-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210692-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210692-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A210692-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A210692-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A210692-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A210692-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A210692-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A210692-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A210692-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A210692-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A210692-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A210692-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A210692-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A210692-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A210692-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A210692-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A210692-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A210692-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A210692-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A210692-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A210692-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A210692-001	AB	1	`e64feba35796…`

Additional Listing Data#

Finished product: Yes
Brand name base: Atovaquone
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ATOVAQUONE	750 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
Y883P1Z2LT	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308429	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
ba3cad0d-cce9-424f-ba5c-557dba8bef12	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4a3a9d58-de64-b317-9153-f2c3fc3a43c9	Product name	8	20220517
7beb5026-9819-5e26-fae7-eca2788430de	Product name	2	20150108

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
70166-488-05	2025-03-25	These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992
70166-488-10	2025-03-25	These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992
70166-488-05	2023-01-30	These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992
70166-488-10	2023-01-30	These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspension Initial U.S. Approval: 1992

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
70166-488-05	Atovaquone	5 mL in 1 CUP, UNIT-DOSE	SUSPENSION	5	2
70166-488-05	Atovaquone	50 in 1 CARTON	SUSPENSION	50	2
70166-488-10	Atovaquone	5 mL in 1 SYRINGE, PLASTIC	SUSPENSION	5	2
70166-488-10	Atovaquone	30 in 1 CARTON	SUSPENSION	30	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70166-488	ATOVAQUONE SUSPENSION [LOHXA]	2	Current NDC, Legacy NDC, 4 package rows	20250327_ba3cad0d-cce9-424f-ba5c-557dba8bef12.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Atovaquone	ATOVAQUONE	Camber Pharmaceuticals, Inc.	2445304e-4b4e-4358-b098-31f3c49c52ef	2026-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210692 application number: ANDA210692
Atovaquone	ATOVAQUONE	American Health Packaging	1a8a43a2-bc26-4ee5-aa35-22a5477a7129	2025-10-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210692 application number: ANDA210692
Atovaquone	ATOVAQUONE	ATLANTIC BIOLOGICALS CORP.	40331de7-819e-5965-e063-6294a90ac91d	2025-10-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210692 application number: ANDA210692
Atovaquone	ATOVAQUONE	ATLANTIC BIOLOGICALS CORP.	f99a8a0c-2b42-4da0-8f5a-e963fc619e8b	2025-05-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210692 application number: ANDA210692
Atovaquone	ATOVAQUONE	Lohxa	ba3cad0d-cce9-424f-ba5c-557dba8bef12	2025-03-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210692 application number: ANDA210692 ndc (package): 70166-488-05 ndc (product): 70166-488 ndc11 (package): 70166048805
Atovaquone	ATOVAQUONE	NorthStar RxLLC	fc7bdd97-f780-4eed-80e0-72e70267b21a	2024-04-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210692 application number: ANDA210692
ATOVAQUONE	ATOVAQUONE	Lupin Pharmaceuticals, Inc.	03ddcc33-729c-4d46-ae6b-2ee47978ba16	2021-06-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210692 application number: ANDA210692

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
Y883P1Z2LT	ATOVAQUONE	95233-18-4	ATOVAQUONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308429	atovaquone 750 MG in 5 mL Oral Suspension	PSN	ba3cad0d-cce9-424f-ba5c-557dba8bef12	2
308429	atovaquone 150 MG/ML Oral Suspension	SCD	ba3cad0d-cce9-424f-ba5c-557dba8bef12	2
308429	atovaquone 1500 MG per 10 ML Oral Suspension	SY	ba3cad0d-cce9-424f-ba5c-557dba8bef12	2
308429	atovaquone 750 MG per 5 ML Oral Suspension	SY	ba3cad0d-cce9-424f-ba5c-557dba8bef12	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
70166-488-05	70166048805	50 CUP, UNIT-DOSE in 1 CARTON (70166-488-05) > 5 mL in 1 CUP, UNIT-DOSE	2018-12-03	0000-00-00	No	No	Current